Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Healthcare Plans

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations and stop loss insurance. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Revenue projections:

Revenue projections for CI
Revenue projections for CI

With CI's revenues forecasted to be lower than last year's, investors are expected to be cautious. A decline in revenue typically harms the company's bottom line, reducing profitability and making investors less confident about the company's ability to sustain its financial health.

Financial Ratios:

currentRatio 0.849000
forwardPE 8.317278
debtToEquity 75.137000
earningsGrowth -0.093000
revenueGrowth 0.104000
grossMargins 0.092980
operatingMargins 0.035300
trailingEps 22.190000
forwardEps 33.415980

The Cigna Group's low growth in both earnings and revenue indicates a likely decrease in profits. This suggests the company may be facing financial challenges, and investors should be cautious about its future performance.
CI's negative gross and operating margins indicate that the company is operating at a loss. This reflects an inability to cover production costs and operational expenses, which could undermine its financial stability.
The Cigna Group's forward EPS being higher than its trailing EPS suggests that the company is expected to generate stronger profits this year. This points to improving financial performance, with The Cigna Group anticipated to deliver better earnings than it did in the prior year.

Price projections:

Price projections for CI
Price projections for CI

The price of CI currently does not indicate any clear risks or opportunities when compared to projections. This balanced stance suggests that investors may prefer to hold off on major decisions until new information arises.

Insider Transactions:

Insider Transactions for CI
Insider Transactions for CI


6 sales transactions of CI were conducted, with market price at 307.3566640218099.CI had 1 buy transactions, with market price of 258.6199951171875.CI is seeing more buys than sells at current price levels, which may indicate a positive market outlook. This trend suggests growing confidence among investors, who appear to expect favorable performance from the stock.

Recommendation changes over time:

Recommendations trend for CI
Recommendations trend for CI


Analysts' buy bias for The Cigna Group signals that the stock is considered a favorable investment. This outlook might prompt investors to allocate funds to The Cigna Group, seeing it as a solid and profitable choice to park their money and potentially benefit from the company's long-term growth.